Intracranial hypertension is abnormally high pressure inside the skull. Normal pressure in the brain ranges from 7 to 15 mmHg in a resting adult, and readings above 20 mmHg are considered elevated and potentially dangerous. The condition can develop because of a known cause, like a blood clot or brain tumor, or it can appear without any obvious explanation, in which case it’s called idiopathic intracranial hypertension (IIH).
How Pressure Builds Inside the Skull
Your brain floats in cerebrospinal fluid (CSF), a clear liquid that cushions and nourishes it. Specialized tissue called the choroid plexus produces this fluid continuously, and it drains back into the bloodstream through small structures along the brain’s surface and through lymphatic pathways near the base of the skull. In a healthy system, production and drainage stay balanced, keeping pressure stable.
When something disrupts that balance, fluid accumulates faster than it can drain, and pressure rises. This can happen if CSF production increases, if the drainage pathways narrow or become blocked, or if blood flow leaving the brain through its veins is restricted. In some people, narrowing of the large veins that drain the brain (called dural venous sinuses) creates a bottleneck that raises pressure even without a tumor or infection present.
Idiopathic vs. Secondary Forms
When doctors can’t identify a structural cause like a tumor, blood clot, or infection, the diagnosis is idiopathic intracranial hypertension. IIH is a diagnosis of exclusion: imaging must show no mass or fluid buildup in the brain’s ventricles, and the spinal fluid itself must have a normal composition. It predominantly affects women of childbearing age, and obesity is the strongest known risk factor.
Secondary intracranial hypertension has a traceable cause. Several medications are known triggers, with estrogen-containing hormones, tetracycline antibiotics, corticosteroids (particularly during withdrawal), and high-dose vitamin A or its derivatives being the most commonly implicated. Other drugs, including certain antibiotics like gentamicin and penicillin, have been reported as rare causes. Medical conditions that obstruct venous drainage from the brain, blood clots in the brain’s venous sinuses, and severe infections can all raise intracranial pressure as well.
What Intracranial Hypertension Feels Like
The hallmark symptom is a persistent headache, often described as pressure-like and sometimes worse when lying down or first thing in the morning. Unlike a typical tension headache, it may intensify with coughing, straining, or bending over, all of which temporarily increase pressure inside the skull.
Vision problems are what make this condition particularly concerning. Many people experience brief episodes of blurred or blacked-out vision lasting a few seconds, called transient visual obscurations. These happen when the swollen optic nerve momentarily loses blood flow. Double vision is also common, caused by pressure on the nerve that controls outward eye movement. Over time, untreated high pressure can damage the optic nerve permanently, leading to blind spots and loss of peripheral vision.
Pulsatile tinnitus, a rhythmic whooshing sound in one or both ears that matches your heartbeat, is another distinctive feature. Neck and shoulder pain round out the typical symptom picture, though not everyone experiences every symptom.
How It’s Diagnosed
Diagnosis typically involves brain imaging followed by a lumbar puncture (spinal tap). The imaging, usually an MRI, rules out tumors, blood clots, and other structural problems. Certain imaging signs can suggest high pressure, including flattening of the back of the eyeball, an empty-looking pituitary gland, and distended sheaths around the optic nerves.
During the lumbar puncture, a needle is placed into the lower spine and the “opening pressure” of the spinal fluid is measured. Normal opening pressure ranges from 10 to 20 cm of water. A reading above 25 cm of water supports a diagnosis of intracranial hypertension. The fluid sample is also tested to confirm its composition is normal, which helps distinguish IIH from infections or other conditions.
An eye exam is essential. Doctors look for papilledema, which is swelling of the optic disc where the nerve enters the back of the eye. The severity is graded on a 0-to-5 scale: grade 0 is normal, grade 1 shows subtle haziness around the disc, and by grade 5, the swelling is so severe that blood vessels on and leaving the disc are completely obscured. This grading helps track whether treatment is working.
First-Line Treatment: Weight Loss and Medication
For IIH, weight loss is one of the most effective interventions. A study of women with IIH and a BMI above 35 found that losing approximately 24% of baseline body weight was associated with disease remission, bringing intracranial pressure back to normal levels. Even more modest weight loss can improve symptoms, and a low-sodium diet is typically recommended alongside it.
The primary medication is acetazolamide, a drug that works by inhibiting an enzyme in the choroid plexus, reducing CSF production by roughly 50%. Treatment usually starts at 500 mg twice daily and can be increased up to 4 grams per day depending on response and tolerability. Clinical trials have shown it improves visual function, reduces optic nerve swelling, and lowers spinal fluid pressure. Common side effects include tingling in the hands and feet, fatigue, altered taste (especially with carbonated drinks), and nausea. These are usually manageable but lead some people to need dose adjustments.
Acetazolamide combined with weight loss is recommended as the first-line approach for most patients with IIH and mild to moderate vision loss.
Surgical Options When Medication Isn’t Enough
When symptoms worsen despite medication, or when vision is deteriorating rapidly, several procedures can help. The right choice depends on whether the main problem is vision loss, headache, or both.
Optic Nerve Sheath Fenestration
This procedure creates small openings in the sheath surrounding the optic nerve to relieve pressure directly on the nerve. It’s typically chosen when vision loss is the primary concern but headaches are manageable. Vision improves in about 59% of patients and stabilizes in an additional 36%, meaning sight is preserved or improved in roughly 95% of treated eyes. Papilledema improves in 80% of cases. About 15% of patients need a repeat procedure. Major complications are rare at 1.5%, though minor complications like temporary double vision occur in about 16% of cases.
CSF Shunting
Shunts are small tubes surgically placed to divert excess spinal fluid from the brain or spine into the abdomen, where the body absorbs it. This approach is especially effective for headache, with 80% of patients reporting improvement, though vision improves in about 54%. The trade-off is a higher need for follow-up surgery: 43% of patients eventually require at least one additional operation, often because shunts can clog or shift position. Minor complications occur in about a third of patients.
Venous Sinus Stenting
In patients whose intracranial hypertension is driven by narrowing of the brain’s venous drainage channels, a stent (a small mesh tube) can be placed inside the narrowed vein to hold it open. This approach has shown strong results: headache improved in 83% of patients, vision in 78%, and papilledema in 97%. The complication rates are lower than shunting, with major complications at about 3% and minor complications at 4.4%. About 10% of patients need a repeat procedure. Stenting is typically considered for patients who haven’t responded to other treatments or who have a clearly identifiable narrowing pattern on imaging.
Long-Term Outlook and Monitoring
Intracranial hypertension is a chronic condition for many people, particularly those with IIH. Some patients achieve lasting remission through weight loss, while others require ongoing medication or repeated interventions. The most serious long-term risk is permanent vision loss, which is why regular eye exams with visual field testing and optic nerve imaging are a core part of follow-up care.
Secondary intracranial hypertension often resolves once the underlying cause is treated. Stopping an offending medication or resolving a venous clot can bring pressure back to normal relatively quickly, though any vision damage that occurred before treatment may not fully reverse. The key in either form is early recognition: the sooner pressure is controlled, the better the chances of preserving sight.